Jean-Patrice Baillargeon

Financement

• Subvention. A pragmatic, individualized, e-health lifestyle intervention to optimize cardiometabolic health in pregnancy planning women and their partners: setting the stage for improved intergenerational health across diverse Canadian communities. Canadian Institutes of Health Research (Ottawa, Canada). 20 000 $. (2024-2025).
  Numéro de subvention : 202402EL8. Voir plus
• Subvention. Promoting healthy eating in early pregnancy in women at risk of gestational diabetes mellitus: does it improve glucose homeostasis?. Canadian Institutes of Health Research (Ottawa, Canada). 554 624 $. (2023-2027).
  Numéro de subvention : 202209PJT. Voir plus
• Subvention. Promoting healthy eating in early pregnancy in women at risk of gestational diabetes mellitus: does it improve glucose homeostasis?. Canadian Institutes of Health Research (Ottawa, Canada). 100 000 $. (2022-2023).
  Numéro de subvention : 202109PJ9. Voir plus
• Subvention. HeLTI cooperative research project: A Multifaceted Maternal-Child Health Intervention Cohort Study for the prevention of childhood obesity. Canadian Institutes of Health Research (Ottawa, Canada). 2 500 000 $. (2022-2027).
  Numéro de subvention : 202112HTC. Voir plus
• Subvention. SmartMoms Canada: An evaluation of a mobile app intervention to support a healthy pregnancy. Canadian Institutes of Health Research (Ottawa, Canada). 439 874 $. (2021-2024).
  Numéro de subvention : 202104PJT. Voir plus
• Subvention. Using telerehabilitation to support families of children with motor difficulties aged 3-8 years old. A patient-centred, mixed-method innovative pragmatic trial. Canadian Institutes of Health Research (Ottawa, Canada). 108 133 $. (2018-2021).
  Numéro de subvention : 201805MRC. Voir plus
• Subvention. The Fit-for-Fertility Multicenter Randomized-Controlled Trial: Improving Reproductive, Maternal and Neonatal Outcomes in Women with Obesity and Infertility. Canadian Institutes of Health Research (Ottawa, Canada). 781 023 $. (2018-2022).
  Numéro de subvention : 201709PJT. Voir plus
• Subvention. Developmental origins of childhood obesity: tracking the causal epigenetic changes programming adiposity in children. Canadian Institutes of Health Research (Ottawa, Canada). 968 388 $. (2017-2022).
  Numéro de subvention : 201610PJT. Voir plus
• Subvention. Sino-Canada HeLTI: A Multifaceted Community-Family-Mother-Child Intervention Study for the Prevention of Childhood Obesity. Canadian Institutes of Health Research (Ottawa, Canada). 35 000 $. (2016-2017).
  Numéro de subvention : 201604DFT. Voir plus
• Subvention. Sino-Canada HeLTI: A Multifaceted Community-Family-Mother-Child Intervention Study for the Prevention of Childhood Obesity. Canadian Institutes of Health Research (Ottawa, Canada). 2 552 150 $. (2016-2021).
  Numéro de subvention : 201604HLT. Voir plus
• Subvention. Impact de l'activite physique reguliere sur les comorbidites, la forme physique, la qualite de vie et les complications peri-operatoires chez les personnes avec obesite severe. Canadian Institutes of Health Research (Ottawa, Canada). 88 222 $. (2012-2013).
  Numéro de subvention : 201204KRS. Voir plus
• Subvention. Evaluation of clinical outcomes and costs of a transferable interdisciplinary lifestyle intervention pre-and per-pregnancy in obese infertile women. Canadian Institutes of Health Research (Ottawa, Canada). 345 500 $. (2011-2014).
  Numéro de subvention : 201011PHE. Voir plus
• Subvention. Réduire l impact de l obésité sur la santé métabolique et endocrinienne, particulièrement chez la femme : rôle de l obésité dans le développement du syndrome des ovaires polykystiques (via les acides gras), et sa prise en charge en première ligne. Fonds de Recherche du Québec - Santé (Montreal, Canada). 122 476 $. (2011-2015).
  Numéro de subvention : 22719. Voir plus
• Subvention. Prevention et gestion integree du diabete et de l'obesite CSSS-CHUS. Canadian Institutes of Health Research (Ottawa, Canada). 11 645 $. (2011-2012).
  Numéro de subvention : 201010PLH. Voir plus
• Subvention. Networking and partnership development meeting for management of obesity in infertile women. Canadian Institutes of Health Research (Ottawa, Canada). 15 000 $. (2010-2011).
  Numéro de subvention : 201002MPS. Voir plus
• Subvention. Integrated medical and surgical approach for the treatment of severe or complicated obesity. Canadian Institutes of Health Research (Ottawa, Canada). 350 000 $. (2010-2013).
  Numéro de subvention : 200911PHE. Voir plus
• Subvention. Role of insulin action and free fatty acids in the hyperandrogenemia of women with polycystic ovary syndrome. Canadian Institutes of Health Research (Ottawa, Canada). 421 324 $. (2009-2012).
  Numéro de subvention : 200903MOP. Voir plus
• Subvention. Impact of life time body composition on mortality and chronic conditions risk in the elderly. Canadian Institutes of Health Research (Ottawa, Canada). 118 333 $. (2009-2011).
  Numéro de subvention : 200802SIB. Voir plus
• Subvention. Networking/partnership development meeting for cost-effective management of obesity in primary care. Canadian Institutes of Health Research (Ottawa, Canada). 25 000 $. (2009).
  Numéro de subvention : 200810MPS. Voir plus
• Subvention. Role of insulin action and free fatty acids in the hyperandrogenemia of women with polycystic ovary syndrome. Canadian Institutes of Health Research (Ottawa, Canada). 100 000 $. (2009).
  Numéro de subvention : 200809IGO. Voir plus
• Subvention. Impact of an integrated obesity management system on patients' care. Canadian Institutes of Health Research (Ottawa, Canada). 150 000 $. (2008-2011).
  Numéro de subvention : 200803PHE. Voir plus
• Subvention. Rôle de l action de l insuline dans l hyperandrogénémie des femmes avec un syndrome des ovaires polykystiques. Fonds de Recherche du Québec - Santé (Montreal, Canada). 71 552 $. (2007-2011).
  Numéro de subvention : 12131. Voir plus
• Subvention. Integrated obesity care management system/ Programme integre de prise en charge de l'obesite. Canadian Institutes of Health Research (Ottawa, Canada). 100 000 $. (2005-2008).
  Numéro de subvention : 200505PHE. Voir plus
• Subvention. Respective role of insulin and LH in the ovarian steroidogenic hyper-responsiveness of non-obese women with PCOS and normal insulin levels. Canadian Institutes of Health Research (Ottawa, Canada). 127 055 $. (2003-2006).
  Numéro de subvention : 200209MOP. Voir plus

Publications

Articles

• Noreth Muller-Kluits, Tracey Smythe, Callista Kahonde, Daniella Watson, Lerato Mohlomi, Tsakani Hlungwani, Caitlin V. Gardiner, Neusa Torres, Jean-Patrice Baillargeon, Stephen Lye, William Fraser, Jianxia Fan, Kumar Gavali Suryanarayana, Kalyanaraman Kumaran, Hilary K. Brown, Sara Rotenberg, Mark T. Carew, Manjiri Khare, Zohra S. Lassi, ... Michelle Pentecost. (2025). A Framework for Incorporating a Disability Lens in Women’s Reproductive Health Research and Practice for Healthy Life Trajectories. Women's Reproductive Health. DOI
• Foued Naimi, Christophe Richer dit Laflèche, Marie-Claude Battista, André C. Carpentier, Jean-Patrice Baillargeon. (2025). Antilipolytic Insulin Sensitivity Indices Measured during an Oral Glucose Challenge: Associations with Insulin-Glucose Clamp and Central Adiposity in Women without Diabetes. Endocrinology and Metabolism. DOI
• Audrey St-Laurent, Matea Belan, Farrah Jean-Denis, Marie-France Langlois, Marie-Hélène Pesant, Belina Carranza-Mamane, Karine Duval, Anne-Sophie Morisset, Jean-Patrice Baillargeon. (2025). An interdisciplinary intervention improves lifestyle behaviours in women living with obesity and subfertility: A secondary analysis of a randomized controlled trial. Clinical Nutrition ESPEN. DOI
• Alexandra Thibodeau, Farrah Jean-Denis, Soren Harnois-Leblanc, Patrice Perron, Marie-Eve Mathieu, Frédéric Dallaire, Anne-Sophie Morisset, Martin Brochu, Jean-Patrice Baillargeon. (2025). Obesity-fertility cohort study: protocol for the assessment of children aged 6–12 years and their mothers. BMJ Open. DOI
• Samantha Cote, Thomas-Louis Perron, Jean-Patrice Baillargeon, Christian Bocti, Jean-Francois Lepage, Kevin Whittingstall. (2023). Association of Cumulative Lifetime Exposure to Female Hormones With Cerebral Small Vessel Disease in Postmenopausal Women in the UK Biobank. Neurology. DOI
• Jean-Luc Ardilouze, Fernand Gobeil, Ran Cheng, Julie Ménard, Danijela Bovan, Virginie Messier, Martin Savard, Jean-Patrice Baillargeon, Rémi Rabasa-Lhoret. (2023). Can a Mixture of Insulin and a Nonsteroidal Anti-inflammatory Drug Prolong Insulin Pump Catheter Wear Time in Adults With Type 1 Diabetes?. Canadian Journal of Diabetes. DOI
• Emily Evans-Hoeker, Zheng Wang, Henk Groen, Astrid E P Cantineau, Ann Thurin‐Kjellberg, Christina Bergh, Joop S E Laven, Alexandra Dietz de Loos, Geranne Jiskoot, Jean-Patrice Baillargeon, Stefano Palomba, Kyra Sim, Lisa J Moran, Juan J Espinós, Trine Moholdt, Amy E Rothberg, Donna Shoupe, Annemieke Hoek, Richard S Legro, ... Rui Wang. (2022). Dietary and/or physical activity interventions in women with overweight or obesity prior to fertility treatment: protocol for a systematic review and individual participant data meta-analysis. BMJ Open. DOI
• Harnois-Leblanc, S., Hernandez, M.I., Codner, E., Cassorla, F., Oberfield, S.E., Leibel, N.I., Mathew, R.P., Ten, S., Magoffin, D.A., Lane, C.J., Goran, M.I., Azziz, R., Baillargeon, J.-P., Geller, D.H. (2022). Profile of Daughters and Sisters of Women with Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance. Journal of Clinical Endocrinology and Metabolism. DOI
• Belan, M., Gélinas, M., Carranza-Mamane, B., Langlois, M.-F., Morisset, A.-S., Ruchat, S.-M., Lavoie, K., Adamo, K., Poder, T., Gallagher, F., Pesant, M.-H., Jean-Denis, F., Baillargeon, J.-P. (2022). Protocol of the Fit-For-Fertility study: a multicentre randomised controlled trial assessing a lifestyle programme targeting women with obesity and infertility. BMJ Open. DOI
• Hardy, I., Lloyd, A., Morisset, A.-S., Camirand Lemyre, F., Baillargeon, J.-P., Fraser, W.D. (2021). Healthy for My Baby Research Protocol- a Randomized Controlled Trial Assessing a Preconception Intervention to Improve the Lifestyle of Overweight Women and Their Partners. Frontiers in Public Health. DOI
• Wu, Y., Marc, I., Bouchard, L., Ouyang, F., Luo, Z.-C., Fan, J., Dubois, L., Mâsse, B., Zhang, J., Leung, P.C.K., Liao, X.P., Herba, C.M., Booij, L., Shen, J., Lewin, A., Jiang, H., Wang, L., Xu, J., Wu, W., ... Huang, H.-F. (2021). Study protocol for the Sino-Canadian Healthy Life Trajectories Initiative (SCHeLTI): A multicentre, cluster-randomised, parallel-group, superiority trial of a multifaceted community-family-mother-child intervention to prevent childhood overweight and obesity. BMJ Open. DOI
• Camden, C., Zwicker, J.G., Morin, M., Schuster, T., Couture, M., Poder, T.G., Maltais, D.B., Battista, M.-C., Baillargeon, J.-P., Goyette, M., Pratte, G., Hurtubise, K., Phoenix, M., Nguyen, T., Berbari, J., Tousignant, M. (2021). Web-based early intervention for children with motor difficulties aged 3-8 years old using multimodal rehabilitation (WECARE): Protocol of a patient-centred pragmatic randomised trial of paediatric telerehabilitation to support families. BMJ Open. DOI
• Guay, S.-P., Houde, A.-A., Breton, E., Baillargeon, J.-P., Perron, P., Gaudet, D., Hivert, M.-F., Brisson, D., Bouchard, L. (2020). DNA methylation at LRP1 gene locus mediates the association between maternal total cholesterol changes in pregnancy and cord blood leptin levels. Journal of Developmental Origins of Health and Disease. DOI
• Baillargeon, J.-P., St-Cyr-Tribble, D., Xhignesse, M., Brown, C., Carpentier, A.C., Fortin, M., Grant, A., Simoneau-Roy, J., Langlois, M.-F. (2020). Impact of an educational intervention combining clinical obesity preceptorship with electronic networking tools on primary care professionals: a prospective study. BMC Medical Education. DOI
• Héroux, J., Belley-Côté, E., Echavé, P., Loignon, M.-J., Bessette, P.-O., Patenaude, N., Baillargeon, J.-P., D'Aragon, F. (2019). Functional recovery with peripheral nerve block versus general anesthesia for upper limb surgery: A systematic review protocol. Systematic Reviews. DOI
• Connolly, A., Holleran, B.J., Simard, É., Baillargeon, J.-P., Lavigne, P., Leduc, R. (2019). Interplay between intracellular loop 1 and helix VIII of the angiotensin II type 2 receptor controls its activation. Biochemical Pharmacology. DOI
• Belan, M., Carranza-Mamane, B., Pesant, M.H., AinMelk, Y., Duval, K., Jean-Denis, F., Langlois, M.F., Baillargeon, J.P. (2019). Male partners of subfertile couples in which the spouse is obese display adverse weight and lifestyle associated with reduced sperm quality. Obesity Research and Clinical Practice. DOI
• Ardilouze, A., Bouchard, P., Hivert, M.-F., Simard, C., Allard, C., Garant, M.-P., Ménard, J., Ouellet, A., Houde, G., Pesant, M.-H., Baillargeon, J.-P., Ardilouze, J.-L. (2019). Self-Monitoring of Blood Glucose: A Complementary Method Beyond the Oral Glucose Tolerance Test to Identify Hyperglycemia During Pregnancy. Canadian Journal of Diabetes. DOI
• Khan, A.A., Koch, C.A., Van Uum, S., Baillargeon, J.P., Bollerslev, J., Brandi, M.L., Marcocci, C., Rejnmark, L., Rizzoli, R., Shrayyef, M.Z., Thakker, R., Yildiz, B.O., Clarke, B. (2019). Standards of care for hypoparathyroidism in adults: A Canadian and international consensus. European Journal of Endocrinology. DOI
• Alexandre Connolly, Samuel Leblanc, Jean-Patrice Baillargeon. (2018). Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome. International Journal of Endocrinology. DOI
• Belan, M., Harnois-Leblanc, S., Laferrère, B., Baillargeon, J.-P. (2018). Optimizing reproductive health in women with obesity and infertility. CMAJ. DOI
• Baillot, A., Baillargeon, J.-P., Pare, A., Poder, T.G., Brown, C., Langlois, M.-F. (2018). Physical activity assessment and counseling in Quebec family medicine groups. Canadian Family Physician.
• Soren Harnois-Leblanc, Andréanne Trottier, Samuel Leblanc, Marie-Claude Battista, David H. Geller, Jean-Patrice Baillargeon. (2017). Evolution of metabolic alterations 5 Years after early puberty in a cohort of girls predisposed to polycystic ovary syndrome. Reproductive Biology and Endocrinology. DOI
• Belan, M., Pelletier, C., Baillargeon, J.-P. (2017). Alanine Aminotransferase Is a Marker of Lipotoxicity Consequences and Hyperandrogenemia in Women with Polycystic Ovary Syndrome. Metabolic syndrome and related disorders. DOI
• Ardilouze, J.-L., Ménard, J., Gobeil, F., Gagnon-Auger, M., Houde, G., Pesant, M.-H., Rabasa-Lhoret, R., Baillargeon, J.-P. (2016). CSII: Longer Catheter Usage Time, a Reasonable Goal. Journal of Diabetes Science and Technology. DOI
• Baillargeon, J.-P., St-Cyr-Tribble, D., Xhignesse, M., Grant, A., Brown, C., Poder, T.G., Langlois, M.-F. (2016). Erratum to: Impact of an integrated obesity management system on patient's care - research protocol [BMC Obesity, 3, 23 (2016)] DOI: 10.1186/s40608-016-0101-9. BMC Obesity. DOI
• Côté, S., Gagné-Ouellet, V., Guay, S.-P., Allard, C., Houde, A.-A., Perron, P., Baillargeon, J.-P., Gaudet, D., Guérin, R., Brisson, D., Hivert, M.-F., Bouchard, L. (2016). PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns. Clinical Epigenetics. DOI
• Faubert, J., Battista, M.-C., Baillargeon, J.-P. (2016). Physiology and endocrinology symposium: Insulin action and lipotoxicity in the development of polycystic ovary syndrome: A review. Journal of Animal Science. DOI
• Kunach, M., Noll, C., Phoenix, S., Guérin, B., Baillargeon, J.-P., Turcotte, E.E., Carpentier, A.C. (2015). Effect of sex and impaired glucose tolerance on organ-specific dietary fatty acid metabolism in humans. Diabetes. DOI
• Baillot, A., Romain, A.J., Boisvert-Vigneault, K., Audet, M., Baillargeon, J.P., Dionne, I.J., Valiquette, L., Chakra, C.N.A., Avignon, A., Langlois, M.-F. (2015). Effects of lifestyle interventions that include a physical activity component in class II and III obese individuals: A systematic review. PLoS ONE. DOI
• Baillot, A., Baillargeon, J.-P., Brown, C., Poder, T., Langlois, M.-F. (2015). Erratum: The 6-min walk test reflects functional capacity in primary care and obese patients (International Journal of Sports Medicine (2015) 36:06 (503-509) DOI: 10.1055/s-0034-1398533). International Journal of Sports Medicine. DOI
• Bellanger, S., Benrezzak, O., Battista, M.C., Naimi, F., Labbè, S.M., Frisch, F., Normand-Lauzière, F., Gallo-Payet, N., Carpentier, A.C., Baillargeon, J.-P. (2015). Experimental dog model for assessment of fasting and postprandial fatty acid metabolism: Pitfalls and feasibility. Laboratory Animals. DOI
• Gervais, A., Battista, M.-C., Carranza-Mamane, B., Lavoie, H.B., Baillargeon, J.-P. (2015). Follicular fluid concentrations of lipids and their metabolites are associated with intraovarian gonadotropin-stimulated androgen production in women undergoing in vitro fertilization. Journal of Clinical Endocrinology and Metabolism. DOI
• Houde, A.-A., Ruchat, S.-M., Allard, C., Baillargeon, J.-P., St-Pierre, J., Perron, P., Gaudet, D., Brisson, D., Hivert, M.-F., Bouchard, L. (2015). LRP1B, BRD2 and CACNA1D: New candidate genes in fetal metabolic programming of newborns exposed to maternal hyperglycemia. Epigenomics. DOI
• Carreau, A.-M., Baillargeon, J.-P. (2015). PCOS in Adolescence and Type 2 Diabetes. Current Diabetes Reports. DOI
• Castellano, C.-A., Baillargeon, J.-P., Nugent, S., Tremblay, S., Fortier, M., Imbeault, H., Duval, J., Cunnane, S.C. (2015). Regional brain glucose hypometabolism in young women with polycystic ovary syndrome: Possible link to mild insulin resistance. PLoS ONE. DOI
• Sotorník, R., Baillargeon, J.-P., Gagnon-Auger, M., Ménard, J., Brassard, P., Ardilouze, J.-L. (2015). Regulation of blood flow in adipose tissue: Involvement of the cholinergic system. American Journal of Physiology - Endocrinology and Metabolism. DOI
• Baillot, A., Baillargeon, J.-P., Brown, C., Langlois, M.-F. (2015). The 6-min walk test reflects functional capacity in primary care and obese patients. International Journal of Sports Medicine. DOI
• Duval, K., Langlois, M.-F., Carranza-Mamane, B., Pesant, M.-H., Hivert, M.-F., Poder, T.G., Lavoie, H.B., Ainmelk, Y., Tribble, D.S.-C., Laredo, S., Greenblatt, E., Sagle, M., Waddell, G., Belisle, S., Riverin, D., Jean-Denis, F., Belan, M., Baillargeon, J.-P. (2015). The Obesity-Fertility Protocol: A randomized controlled trial assessing clinical outcomes and costs of a transferable interdisciplinary lifestyle intervention, before and during pregnancy, in obese infertile women. BMC Obesity. DOI
• Thibault, V., Morisset, A.-S., Brown, C., Carpentier, A.C., Baillargeon, J.-P., Langlois, M.-F., Gagnon, C. (2015). The increase in serum 25-hydroxyvitamin D following weight loss does not contribute to the improvement in insulin sensitivity, insulin secretion and β-cell function. British Journal of Nutrition. DOI
• Leblanc, S., Battista, M.-C., Noll, C., Hallberg, A., Gallo-Payet, N., Carpentier, A.C., Vine, D.F., Baillargeon, J.-P. (2014). Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome. Endocrinology (United States). DOI
• Castellano, C.-A., Baillargeon, J.-P., Plourde, M., Briand, S.I., Angers, P., Giguère, A., Matte, J.J. (2014). Dietary conjugated α-linolenic acid did not improve glucose tolerance in a neonatal pig model. European Journal of Nutrition. DOI
• Desgagné, V., Hivert, M.-F., St-Pierre, J., Guay, S.-P., Baillargeon, J.-P., Perron, P., Gaudet, D., Brisson, D., Bouchard, L. (2014). Epigenetic dysregulation of the IGF system in placenta of newborns exposed to maternal impaired glucose tolerance. Epigenomics. DOI
• Unfer, V., Carlomagno, G., Papaleo, E., Vailati, S., Candiani, M., Baillargeon, J.-P. (2014). Hyperinsulinemia alters myoinositol to d-chiroinositol ratio in the follicular fluid of patients with PCOS. Reproductive Sciences. DOI
• Baillargeon, J.-P., St-Cyr-Tribble, D., Xhignesse, M., Grant, A., Brown, C., Langlois, M.-F. (2014). Impact of an integrated obesity management system on patient's care - research protocol. BMC Obesity. DOI
• Baillot, A., Audet, M., Baillargeon, J.P., Dionne, I.J., Valiquette, L., Rosa-Fortin, M.M., Abou Chakra, C.N., Comeau, E., Langlois, M.F. (2014). Impact of physical activity and fitness in class II and III obese individuals: A systematic review. Obesity Reviews. DOI
• Labbé, S.M., Noll, C., Grenier-Larouche, T., Kunach, M., Bouffard, L., Phoenix, S., Guérin, B., Baillargeon, J.-P., Langlois, M.-F., Turcotte, E.E., Carpentier, A.C. (2014). Improved cardiac function and dietary fatty acid metabolism after modest weight loss in subjects with impaired glucose tolerance. American Journal of Physiology - Endocrinology and Metabolism. DOI
• Biet, M., Morin, N., Benrezzak, O., Naimi, F., Bellanger, S., Baillargeon, J.P., Chouinard, L., Gallo-Payet, N., Carpentier, A.C., Dumaine, R. (2014). Lasting alterations of the sodium current by short-term hyperlipidemia as a mechanism for initiation of cardiac remodeling. American Journal of Physiology - Heart and Circulatory Physiology. DOI
• Houde, A.A., St-Pierre, J., Hivert, M.F., Baillargeon, J.P., Perron, P., Gaudet, D., Brisson, D., Bouchard, L. (2014). Placental lipoprotein lipase DNA methylation levels are associated with gestational diabetes mellitus and maternal and cord blood lipid profiles. Journal of Developmental Origins of Health and Disease. DOI
• Houde, A.-A., Guay, S.-P., Desgagné, V., Hivert, M.-F., Baillargeon, J.-P., St-Pierre, J., Perron, P., Gaudet, D., Brisson, D., Bouchard, L. (2013). Adaptations of placental and cord blood ABCA1 DNA methylation profile to maternal metabolic status. Epigenetics. DOI
• Shum, M., Pinard, S., Guimond, M.-O., Labbé, S.M., Roberge, C., Baillargeon, J.-P., Langlois, M.-F., Alterman, M., Wallinder, C., Hallberg, A., Carpentier, A.C., Gallo-Payet, N. (2013). Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats. American Journal of Physiology - Endocrinology and Metabolism. DOI
• Ruchat, S.-M., Houde, A.-A., Voisin, G., St-Pierre, J., Perron, P., Baillargeon, J.-P., Gaudet, D., Hivert, M.-F., Brisson, D., Bouchard, L. (2013). Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases. Epigenetics. DOI
• Bouchard, D.R., Langlois, M.-F., Boisvert-Vigneault, K., Farand, P., Paulin, M., Baillargeon, J.-P. (2013). Pilot study: Can older inactive adults learn how to reach the required intensity of physical activity guideline?. Clinical Interventions in Aging. DOI
• Bouchard, D.R., Porneala, B., Janssen, I., Langlois, M.-F., Baillargeon, J.-P., Fox, C.S., Meigs, J.B., D'Agostino Sr., R.B., Pencina, M., Hivert, M.-F. (2013). Risk of type 2 diabetes and cumulative excess weight exposure in the Framingham Offspring Study. Journal of Diabetes and its Complications. DOI
• Bouchard, D.R., Baillargeon, J.-P., Langlois, M.-F. (2013). The Independent Effect of Age Groups on the Effectiveness of Lifestyle Intervention. Current Obesity Reports. DOI
• Gallo-Payet, N., Shum, M., Baillargeon, J.-P., Langlois, M.-F., Wallinder, C., Alterman, M., Hallberg, A., Carpentier, A.C. (2012). AT2 receptor agonists: Exploiting the beneficial Arm of Ang II signaling. Current Hypertension Reviews. DOI
• Trottier, A., Battista, M.-C., Geller, D.H., Moreau, B., Carpentier, A.C., Simoneau-Roy, J., Baillargeon, J.-P. (2012). Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome. Fertility and Sterility. DOI
• Bouchard, D.R., Langlois, M.-F., Domingue, M.-E., Brown, C., Lebrun, V., Baillargeon, J.-P. (2012). Age differences in expectations and readiness regarding lifestyle modifications in individuals at high risk of diabetes. Archives of Physical Medicine and Rehabilitation. DOI
• Henderson, M., Baillargeon, J.P., Rabasa-Lhoret, R., Chiasson, J.L., Hanley, J., Lambert, M. (2012). Estimating insulin secretion in youth using simple indices derived from the oral glucose tolerance test. Diabetes and Metabolism. DOI
• Ardilouze, J.-L., Mahdavian, M., Baillargeon, J.-P., Hivert, M.-F. (2012). Glucose challenge test for detecting gestational diabetes mellitus: A systematic review. BJOG: An International Journal of Obstetrics and Gynaecology. DOI
• Bouchard, D.R., Baillargeon, J.-P., Gagnon, C., Brown, C., Langlois, M.-F. (2012). Impact of health professionals' contact frequency on response to a lifestyle intervention with individuals at high risk for diabetes. Diabetes Research and Clinical Practice. DOI
• Pesant, M.-H., Desmarais, G., Fink, G.D., Baillargeon, J.-P. (2012). Reference ranges for total and calculated free and bioavailable testosterone in a young healthy women population with normal menstrual cycles or using oral contraception. Clinical Biochemistry. DOI
• Bellanger, S., Battista, M.-C., Fink, G.D., Baillargeon, J.-P. (2012). Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells. Steroids. DOI
• Gagnon, C., Brown, C., Couture, C., Kamga-Ngande, C.N., Hivert, M.F., Baillargeon, J.P., Carpentier, A.C., Langlois, M.F. (2011). A cost-effective moderate-intensity interdisciplinary weight-management programme for individuals with prediabetes. Diabetes and Metabolism. DOI
• Zhao, L., Li, W., Han, F., Hou, L., Baillargeon, J.-P., Kuang, H., Wang, Y., Wu, X. (2011). Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro. Fertility and Sterility. DOI
• Pesant, M.-H., Baillargeon, J.-P. (2011). Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndrome. Fertility and Sterility. DOI
• Battista, M.-C., Hivert, M.-F., Duval, K., Baillargeon, J.-P. (2011). Intergenerational cycle of obesity and diabetes: How can we reduce the burdens of these conditions on the health of future generations?. Experimental Diabetes Research. DOI
• Henderson, M., Rabasa-Lhoret, R., Bastard, J.-P., Chiasson, J.-L., Baillargeon, J.-P., Hanley, J.A., Lambert, M. (2011). Measuring insulin sensitivity in youth: How do the different indices compare with the gold-standard method?,Comparaison entre différents indices permettant d'estimer la sensibilité à l'insuline chez l'enfant et la méthode de référence du clamp hyperinsulinémique euglycémique. Diabetes and Metabolism. DOI
• Bouchard, D.R., Langlois, M.-F., Brochu, M., Dionne, I.J., Baillargeon, J.-P. (2011). Metabolically healthy obese women and functional capacity. Metabolic Syndrome and Related Disorders. DOI
• Maymone, A.C., Baillargeon, J.-P., Ménard, J., Ardilouze, J.-L. (2011). Oral hypoglycemic agents for gestational diabetes mellitus?. Expert Opinion on Drug Safety. DOI
• Wickham III, E.P., Cheang, K.I., Clore, J.N., Baillargeon, J.-P., Nestler, J.E. (2011). Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome. Metabolism: Clinical and Experimental. DOI
• Ardilouze, J.-L., Mahdavian, M., Baillargeon, J.-P. (2010). Brick by brick: Metformin for gestational diabetes mellitus?. Expert Review of Endocrinology and Metabolism. DOI
• Pelletier, L., Baillargeon, J.-P. (2010). Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice. Fertility and Sterility. DOI
• Gagnon, C., Ménard, J., Bourbonnais, A., Ardilouze, J.-L., Baillargeon, J.-P., Carpentier, A.C., Langlois, M.-F. (2010). Comparison of foot-to-foot and hand-to-foot bioelectrical impedance methods in a population with a wide range of body mass indices. Metabolic Syndrome and Related Disorders. DOI
• Massicotte, M.-H., Langlois, F., Baillargeon, J.-P. (2010). Current procedures for managing polycystic ovary syndrome. Expert Review of Obstetrics and Gynecology. DOI
• Gagnon-Auger, M., Du Souich, P., Baillargeon, J.-P., Martin, E., Brassard, P., Ménard, J., Ardilouze, J.-L. (2010). Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: A pharmacokinetic and pharmacodynamic study. Diabetes Care. DOI
• Mahdavian, M., Hivert, M.-F., Baillargeon, J.-P., Menard, J., Ouellet, A., Ardilouze, J.-L. (2010). Gestational diabetes mellitus: Simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose. Diabetes Care. DOI
• Baptiste, C.G., Battista, M.-C., Trottier, A., Baillargeon, J.-P. (2010). Insulin and hyperandrogenism in women with polycystic ovary syndrome. Journal of Steroid Biochemistry and Molecular Biology. DOI
• Kong, W., Langlois, M.-F., Kamga-Ngandé, C., Gagnon, C., Brown, C., Baillargeon, J.-P. (2010). Predictors of success to weight-loss intervention program in individuals at high risk for type 2 diabetes. Diabetes Research and Clinical Practice. DOI
• Gagnon, C., Baillargeon, J.-P., Desmarais, G., Fink, G.D. (2010). Prevalence and predictors of vitamin D insufficiency in women of reproductive age living in northern latitude. European Journal of Endocrinology. DOI
• Baillargeon, J.-P., Iuorno, M.J., Apridonidze, T., Nestler, J.E. (2010). Uncoupling between insulin and release of a d-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women with polycystic ovary syndrome. Metabolic Syndrome and Related Disorders. DOI
• Papaleo, E., Unfer, V., Baillargeon, J.P., Chiu, T.T. (2009). Contribution of myo-inositol to reproduction. European Journal of Obstetrics and Gynecology and Reproductive Biology. DOI
• Kamga-Ngandé, C.N., Carpentier, A.C., Nadeau-Marcotte, F., Ardilouze, J.-L., Baillargeon, J.-P., Bellabarba, D., Houde, G., Langlois, M.-F. (2009). Effectiveness of a multidisciplinary program for management of obesity: The Unité d'Enseignement, de Traitement et de Recherche sur l'Obésité (UETRO) database study. Metabolic Syndrome and Related Disorders. DOI
• Villeneuve, M.-C., Ostlund Jr., R.E., Baillargeon, J.-P. (2009). Hyperinsulinemia is closely related to low urinary clearance of d-chiro-inositol in men with a wide range of insulin sensitivity. Metabolism: Clinical and Experimental. DOI
• Papaleo, E., Unfer, V., Baillargeon, J.-P., Fusi, F., Occhi, F., De Santis, L. (2009). Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertility and Sterility. DOI
• Lavoie, F., Frisch, F., Brassard, P., Normand-Lauziére, F., Cyr, D., Gagnon, R., Drouin, R., Baillargeon, J.-P., Carpentier, A.C. (2009). Relationship between total and high molecular weight adiponectin levels and plasma nonesterified fatty acid tolerance during enhanced intravascular triacylglycerol lipolysis in men. Journal of Clinical Endocrinology and Metabolism. DOI
• Beriault, K., Carpentier, A.C., Gagnon, C., Ménard, J., Baillargeon, J.-P., Ardilouze, J.-L., Langlois, M.-F. (2009). Reproducibility of the 6-minute walk test in obese adults. International Journal of Sports Medicine. DOI
• Brassard, M., AinMelk, Y., Baillargeon, J.-P. (2008). Basic Infertility Including Polycystic Ovary Syndrome. Medical Clinics of North America. DOI
• Baillargeon, J.-P., Nestler, J.E., Ostlund, R.E., Apridonidze, T., Diamanti-Kandarakis, E. (2008). Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. Human Reproduction. DOI
• Brassard, P., Frisch, F., Lavoie, F., Cyr, D., Bourbonnais, A., Cunnane, S.C., Patterson, B.W., Drouin, R., Baillargeon, J.-P., Carpentier, A.C. (2008). Impaired plasma nonesterified fatty acid tolerance is an early defect in the natural history of type 2 diabetes. Journal of Clinical Endocrinology and Metabolism. DOI
• Cheang, K.I., Baillargeon, J.-P., Essah, P.A., Ostlund Jr., R.E., Apridonize, T., Islam, L., Nestler, J.E. (2008). Insulin-stimulated release of d-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. Metabolism: Clinical and Experimental. DOI
• Baillargeon, J.-P., Carpentier, A.C. (2008). Reply: Correlates between hyperinsulinism and hyperandrogenemia?. Fertility and Sterility. DOI
• Roberge, C., Carpentier, A.C., Langlois, M.-F., Baillargeon, J.-P., Ardilouze, J.-L., Maheux, P., Gallo-Payet, N. (2007). Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity. American Journal of Physiology - Endocrinology and Metabolism. DOI
• Baillargeon, J.-P., Carpentier, A.C. (2007). Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects. Diabetologia. DOI
• Baillargeon, J.-P., Carpentier, A., Donovan, D., Fortin, M., Grant, A., Simoneau-Roy, J., St-Cyr-Tribble, D., Xhignesse, M., Langlois, M.-F. (2007). Integrated obesity care management system -implementation and research protocol. BMC Health Services Research. DOI
• Carpentier, A.C., Frisch, F., Brassard, P., Lavoie, F., Bourbonnais, A., Cyr, D., Giguère, R., Baillargeon, J.-P. (2007). Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans. American Journal of Physiology - Endocrinology and Metabolism. DOI
• Papaleo, E., Unfer, V., Baillargeon, J.-P., De Santis, L., Fusi, F., Brigante, C., Marelli, G., Cino, I., Redaelli, A., Ferrari, A. (2007). Myo-inositol in patients with polycystic ovary syndrome: A novel method for ovulation induction. Gynecological Endocrinology. DOI
• Pesant, M.-H., Baillargeon, J.-P. (2007). Ovulation induction in polycystic ovary syndrome - How do metformin and clomifene citrate compare?. Nature Clinical Practice Endocrinology and Metabolism. DOI
• Ménard, J., Payette, H., Dubuc, N., Baillargeon, J.P., Maheux, P., Ardilouze, J.L. (2007). Quality of life in type 2 diabetes patients under intensive multitherapy. Diabetes and Metabolism. DOI
• Baillargeon, J.-P., Carpentier, A. (2007). Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fertility and Sterility. DOI
• Baillargeon, J.-P., Legro, R.S. (2007). Should metformin be used as front-line therapy for fertility in women with PCOS?. Sexuality, Reproduction and Menopause.
• Gagnon, C., Baillargeon, J.-P. (2007). Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome. CMAJ. Canadian Medical Association Journal. DOI
• Baillargeon, J.-P. (2007). View 1: Metformin improves ovulation and pregnancy rates. Sexuality, Reproduction and Menopause.
• Baillargeon, J.-P., Diamanti-Kandarakis, E., Ostlund Jr., R.E., Apridonidze, T., Iuorno, M.J., Nestler, J.E. (2006). Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care. DOI
• Baillargeon, J.-P., Nestler, J.E. (2006). Commentary: Polycystic ovary syndrome: A syndrome of ovarian hypersensitivity to insulin?. Journal of Clinical Endocrinology and Metabolism. DOI
• Pesant, M.-H., Baillargeon, J.-P. (2006). Comparing rosiglitazone with ethinylestradiol/cyproterone acetate in the treatment of polycystic ovary syndrome. Expert Review of Obstetrics and Gynecology. DOI
• Baillargeon, J.-P., McClish, D.K., Essah, P.A., Nestler, J.E. (2005). Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: A meta-analysis. Journal of Clinical Endocrinology and Metabolism. DOI
• Ménard, J., Payette, H., Baillargeon, J.-P., Maheux, P., Lepage, S., Tessier, D., Ardilouze, J.-L. (2005). Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: A randomized controlled trial. CMAJ. Canadian Medical Association Journal. DOI
• Carpentier, A.C., Frisch, F., Cyr, D., Généreux, P., Patterson, B.W., Giguère, R., Baillargeon, J.-P. (2005). On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans. American Journal of Physiology - Endocrinology and Metabolism. DOI
• Baillargeon, J.-P. (2005). Use of insulin sensitizers in polycystic ovarian syndrome. Current Opinion in Investigational Drugs.
• Baillargeon, J.-P., Jakubowicz, D.J., Iuorno, M.J., Jakubowicz, S., Nestler, J.E. (2004). Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertility and Sterility. DOI
• Baillargeon, J.-P., Iuorno, M.J., Jakubowicz, D.J., Apridonidze, T., He, N., Nestler, J.E. (2004). Metformin Therapy Increases Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome. Journal of Clinical Endocrinology and Metabolism. DOI
• Jakubowicz, D.J., Essah, P.A., Seppälä, M., Jakubowicz, S., Baillargeon, J.-P., Koistinen, R., Nestler, J.E. (2004). Reduced Serum Glycodelin and Insulin-Like Growth Factor-Binding Protein-1 in Women with Polycystic Ovary Syndrome during First Trimester of Pregnancy. Journal of Clinical Endocrinology and Metabolism. DOI
• Diamanti-Kandarakis, E., Baillargeon, J.-P., Iuorno, M.J., Jakubowicz, D.J., Nestler, J.E. (2003). Controversies in endocrinology - A modern medical quandary: Polycystic ovary syndrome, insulin resistance, and oral contraceptive pills. Journal of Clinical Endocrinology and Metabolism. DOI
• Baillargeon, J.-P., Iuorno, M.J., Nestler, J.E. (2003). Insulin sensitizers for polycystic ovary syndrome. Clinical Obstetrics and Gynecology. DOI
• Baillargeon, J.-P., Iuorno, M.J., Nestler, J.E. (2002). Comparison of metformin and thiazolidinediones in the management of polycystic ovary syndrome. Current Opinion in Endocrinology and Diabetes. DOI
• Iuorno, M.J., Jakubowicz, D.J., Baillargeon, J.-P., Dillon, P., Gunn, R.D., Allan, G., Nestler, J.E. (2002). Effects of D-chiro-inositol in lean women with the polycystic ovary syndrome. Endocrine Practice. DOI
• Baillargeon, J.-P., Lepage, S., Larrivée, L., Roy, M.-A., Landry, S., Maheux, P. (2001). Intensive surveillance and treatment of dyslipidemia in the postinfarct patient: Evaluation of a nurse-oriented management approach. Canadian Journal of Cardiology.
• Baillargeon, J.P., Lepage, S., Larrivée, L., Roy, M.A., Landry, S., Maheux, P. (2001). Intensive surveillance and treatment of dyslipidemia in the postinfarct patient: evaluation of a nurse-oriented management approach. The Canadian journal of cardiology.
• Baillargeon, J.-P., Pek, B., Teijeira, J., Poisson, J., van Rossum, N., Langlois, M.-F. (2000). Combined surgery for coronary artery disease and pheochromocytoma. Canadian Journal of Anaesthesia. DOI

Chapitres de livre

• Carreau, A.-M., Pesant, M.-H., Baillargeon, J.-P. (2020). Polycystic Ovary Syndrome and Metabolic Syndrome. Contemporary Endocrinology. DOI
• Bellanger, S., Battista, M.-C., Baillargeon, J.-P. (2013). Insulin resistance and lipotoxicity in PCOS: Causes and consequences. Polycystic Ovary Syndrome: Current and Emerging Concepts. DOI
• Baillargeon, J.-P., Farid, N.R. (2009). Medical treatment. Diagnosis and Management of Polycystic Ovary Syndrome. DOI

Autres contributions

Cours enseignés ou supervisés à l'UdeS

• BCM606 - Endocrinologie moléculaire. (2024-2025). (2CR).

Présentations

• (2024). Améliorer la fertilité des femmes obèses par les saines habitudes de santé -- Projet Ferti-Santé. 35e Journée d'Endocrinologie. Métabolisme & Nutrition de Sorbonne Université Médecine, Paris.
• (2024). Breaking Barriers in the Management of Hyperandrogenism. 10th International Diabetes & Endocrinology Conference, Coimbatore.
• (2024). PCOS: 2023 International Guidelines Update. Women's Health: Polycystic Ovary Syndrome. DC/CSEM 2024 Professional Conference, Halifax.
• (2024). TRANS-Formation -- Approche médicale de la personne adulte transgenre ou non-binaire. Grand forum de l'A.P.E.S, Trois-Rivières.
• (2024). The Approach to the Patients with Amenorrhea. 21st International Congress of Endocrinology, Dubaï.
• (2024). « TRANS-Formation Approche médicale de la personne adulte transgenre ou non-binaire ». Grand round, Department of Medicine, Sherbrooke.
• (2024). « TRANS-Formation ». L'Endocrinologie : une journée hormono-positive. Continuous Professional Development Center, Sherbrooke.
• Kumaran K, Birken C, Dennis CL, Fraser WD, Huang H, Fan J, Lye S, Marrhews SG, Norris SA. (2023). An intergenerational life-course approach to adress early chilhood obesity and adiposity: the healthy Life Trajectories Initiative (HELTI). The Lancet Summit: Childhood Obesity: Consequences Across the Life Course, Virtual.
• (2023). Approche médicale de la personne adulte transgenre ou non-binaire. 3è Journées Africaines d'Endocrinologie Clinique Adrien Lokrou (JAECL) de la Société Africaine d'Endocrinologie Métabolisme Nutrition (SAEMN), (Virtual).
• (2023). Beyond Gestational Diabetes Strategies for Preventing Diabetes and Cardiovascular Disease. Pakistan Endocrine Society 21st Annual Conference, Islamabad.
• Thibodeau, A; Baillargeon, JP. (2023). Est-ce possible d'éviter la transmission de l'obésité?. Retraite du CRCHUS. Sherbrooke, October 20, 2023. (Oral presentation), Sherbrooke.
• (2023). Evaluation and treatment of women with hyperandrogenism. The 2nd ISE Endocrinology Practice Latam SMNE 2023, Guadalajara.
• (2023). Improve fertility of women with obesity through healthy lifestyle. Pakistan Endocrine Society 21st Annual Conference, Islamabad.
• (2023). Metabesity and reproduction. The 2nd ISE Endocrinology Practice Latam SMNE 2023, Guadalajara.
• (2023). Syndrome des ovaires polykystiques : Comprendre pour mieux agir. Congrès annuel AMBQ/CAMB annual congress, Montreal.
• (2022). Approche médicale de la personne adulte transgenre ou non-binaire. Symposium Professionnel 2022 - Proxim/Uniprix, Ste-Hyacinthe.
• (2022). Les saines habitudes de vie en préconception et tôt dans la grossesse. Journée annuelle du Centre de recherche en reproduction, développement et santé intergénérationnelle, Quebec.
• (2021). Meet the professor: Lifestyle management for obesity-associated infertility in women. Virtual International Congress of Endocrinology, Buenos Aires.
• (2021). Women's Health -- Fit-for-Fertility: An efficient way to get fit, fertile and a healthy baby. 7th Canadian Obesity Summit (virtual).
• (2019). Preconception Management of Obesity: Getting Fit for Fertility and Fetal Health. 6th Canadian Obesity Summit.
• (2018). A Pharmaceutical Preparation for Improving Infusion Sets Longevity of Continuous Subcutaneous Insulin Infusion Systems (JL Ardilouze, F Gobeil Junior, JP Baillargeon, R Rabasa-Lhoret, J Ménard, M Gagnon-Auger, H Gagnon).
• (2018). Débat: Pilules ou pilates. 8e Journée scientifique de l'axe Diabète, Obésité et complications cardiovasculaires, Sherbrooke.
• (2018). Le diabète de type 2 : perspectives cliniques. Camp d'hiver du Réseau de recherche en santé cardiométabolique, diabète et obésité, Magog-Orford.
• (2017). Le diabète de type 2 : perspectives cliniques. Camp d'hiver du Réseau de recherche en santé cardiométabolique, diabète et obésité, Magog-Orford.
• (2017). Le syndrome des ovaires polykystiques : aller au-delà de la présomption. L'endocrinologie. Fédération des médecins omnipraticiens du Québec, Québec.
• (2017). Les complications du tissu adipeux viscéral. Journée de formation sur les maladies chroniques cardio-métaboliques et respiratoires du CIUSSS de l'Estrie-CHUS, Sherbrooke.
• (2017). Obesity Management in Women with Infertility. 5th Canadian Obesity Summit, Banff.
• (2017). Syndrome des ovaires polykystiques -- Pathophysiologie et anomalies métaboliques. Mise à jour. Association des Médecins Endocrinologues du Québec, Beaupré.
• (2016). A Pharmaceutical Preparation for Improving Absorption and Postprandial Hypoglycemic Action of Insulin (Sold to Eli Lilly in December 2018 - JL Ardilouze, MGagnon-Auger, F Gobeil Junior, J Menard, JP Baillargeon, P Brassard).
• (2016). Le diabète de type 2 : perspectives cliniques. Camp d'hiver du Réseau de recherche en santé cardiométabolique, diabète et obésité, Magog-Orford.
• (2016). Le syndrome des ovaires polykystiques : Quand le gras stimule les hormones !. Conférence G.E. Plante dans la cadre de la journée scientifique du département de médecine, Sherbrooke.
• (2016). Les mythes et les réalités de l'andropause. Centre de formation continue de la Faculté de médecine et des sciences de la santé de l'Université de Sherbrooke, Magog-Orford.
• (2015). Hirsutisme, Une glande c'est bien, mais deux c'est mieux!. Association des spécialistes en médecine interne du Québec, Bromont.
• (2015). Le diabète de type 2 : perspectives cliniques. Camp d'hiver du Réseau de recherche en santé cardiométabolique, diabète et obésité, Magog-Orford.
• (2015). Obésité et Fertilité - Peut-on aider les couples infertiles?. Conférence à l'Université de Trois-Rivières, Trois-Rivières.
• (2015). Syndrome des ovaires polykystiques. Groupe d'Étude en médecine obstétricale du Québec, Bromont.
• (2013). Syndrome des ovaires polykystiques : Dépister pour agir. Associations des Médecins Omnipraticiens de l'Estrie, Sherbrooke.
• (2012). Obesity and Fertility Role of Lifestyle Intervention. Symposium at Society of Obstetricians and Gynaecologists of Canada 68th Annual Clinical Meeting, Ottawa.
• (2012). Symposium on Modifiable Lifestyle Factors Affecting Fertility: Weight, Obesity and Fertility - What can we do to Help our Patients?. Canadian Fertility and Andrology Society 58th Annual Meeting.
• (2011). Integrated obesity management system -- changes in perceptions and practices. Panel expert at the workshop ``Management of obesity in Primary care'' of the 2nd National Obesity Summit sponsored by the Canadian Obesity Network (CON), Montreal.
• (2011). Interventions for Modifiable Lifestyle Factors Related to Obesity. Assisted Human Reproduction Canada Science Advisory Panel, Toronto.
• (2010). Lifestyle factors and infertility. Assisted Human Reproduction Canada/Canadian Fertility and Andrology Society/Society of Obstetricians and Gynaecologists of Canada Tripartite Committee Meeting, Toronto.
• (2009). L'obésité : le nouveau fléau. Centre de formation continue de la Faculté de médecine et des sciences de la santé de l'Université de Sherbrooke, Orford.

Divers

• A. Gervais, G. Ostinelli, J. Faubert, M-C. Battista, B. Carranza-Mamane, H. Lavoie, Jean-Patrice Baillargeon. (2026). Comparison of intra-ovarian metabolic environment between women with or without PCOS undergoing in vitro fertilization.
• Jean-Patrice Baillargeon, Matea Belan, Madélie Giguère-Johnson, Belina Carranza-Mamane, Marie-Hélène Pesant, Youssef AinMelk, Marie-France Langlois, Hélène Lavoie, Ellen M. Greenblatt, Margaret Sagle, Guy Waddell, Farrah Jean-Denis. (2025). Lifestyle intervention before and during fertility treatment in women with obesity or overweight with PCOS – a RCT.